About us

Policy makers, governments and donors are faced with numerous information gaps when considering ways to improve access to health commodities and services, such as artemisinin-based combination therapy (ACT) and malaria diagnostics for malaria, and modern contraceptive methods and procedures for family planning. To help address some of these gaps, two multi-country research projects were launched.


Started in 2008, ACTwatch was intended to fill evidence gaps related to malaria diagnostics, antimalarial medicines and fever case management in the private and public sectors. ACTwatch collected data to inform evidence-based malaria control policies and programmes. ACTwatch was a PSI research project in partnership with LSHTM.

Read more about ACTwatch’s partners and donors.



FPwatch was designed to generate evidence on contraceptive availability through surveys administered to all public and private health facilities and outlets. Launched in 2014, FPwatch provided data on the composition, performance, and service readiness of the total FP market in five countries.

The selected FPwatch countries were identified as high priority for achieving the FP2020 Initiative goal to enable 120 million additional women and girls worldwide to have informed choice and access to family planning (FP) information and a range of modern contraceptive methods by the year 2020.  FPwatch was a PSI research project. 

Read more about FPwatch’s partners and donors.

A private sector drug shop